光生物刺激设备市场：依类型、应用、最终用户、地区划分，2024-2031

光生物刺激设备的市场评估，2024-2031

非侵入性、无药物治疗技术的发展趋势，以及人们对其功效和安全性的认识不断提高，正在推动对光生物刺激设备的需求。据 Verified Market Research 分析师称，预测期内光学生物刺激设备市场估值预计将达到 3.1364 亿美元，低于 2023 年的约 1.9582 亿美元。

随着医疗保健专业人士和消费者意识到光生物刺激疗法的好处，市场正在加速发展，促使这些设备在各种医疗环境中的使用不断增加，预计从2024 年起将会增长，这使得市场的复合年增长率达到6.07。

光生物刺激设备市场定义/概述

光生物刺激装置，也称为低强度雷射疗法 (LLLT) 或冷激光，使用特定波长的光来激活体内的细胞过程。这些设备产生非热、低强度的光，被细胞吸收并引发各种生化反应，促进癒合和组织再生。简而言之，光生物刺激利用光的治疗特性来刺激身体的自然癒合过程，而不会伤害身体。

此外，这些设备也用于各种医疗和美容领域。在医疗保健中，它用于控制关节炎、肌腱炎和运动损伤等疾病引起的疼痛，减少炎症，缓解肌肉骨骼疼痛。光生物刺激装置也已用于伤口癒合，以促进糖尿病溃疡等急慢性伤口的早期恢復。

哪些因素推动光生物刺激装置的发展？

世界人口越来越受到神经性疼痛、肌肉骨骼疾病和关节炎等慢性疾病的影响。因此，光生物刺激装置可以帮助控制疼痛、减少发炎并促进各种环境下的组织癒合，从而增加了对此类治疗方案的需求。

用于疼痛管理和復健的非侵入性方法正在获得医疗保健专业人员和患者的广泛接受。这一趋势得到了越来越多的临床证据的支持，证明了光生物刺激疗法的有效性和安全性，从而促进了其越来越多的采用。

此外，雷射和 LED 技术的不断进步正在开发更有效、便携式且易于使用的光生物刺激设备。这些技术进步不仅提高了治疗效果，而且使其更适合家庭使用，从而促使市场成长。

限制光学生物刺激设备市场成长的限制是什么？

儘管光生物刺激设备具有潜在的好处，但医疗专业人士和消费者都对它们持怀疑态度。说服医疗保健提供者和患者使用新技术可能具有课题性，特别是当人们对这些设备的工作原理知之甚少时。结果，它已成为市场的主要障碍。

获得光生物刺激疗法的保险报销也可能是个问题。许多保险公司对接受新的或正在开发的治疗方法持谨慎态度，除非有强有力的证据表明成本效益或长期效益。这限制了患者获得这些药物的机会，使得某些治疗对某些患者来说自付费用过于昂贵。

此外，美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构的批准也是一大障碍。这些设备必须满足高安全性和有效性要求，并且审批过程既耗时又昂贵。

目录

第一章光生物刺激设备的全球市场：简介

• 市场概览
• 调查范围
• 先决条件

第 2 章执行摘要

第三章验证市场研究研究方法

• 资料探勘
• 验证
• 初步面试
• 资料来源列表

第 4 章光生物刺激设备的全球市场前景

• 摘要
• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第五章光生物刺激设备的全球市场：依类型

• 摘要
• 红外线
• 红灯
• 其他

第 6 章光生物刺激设备的全球市场：依应用分类

• 摘要
• 疼痛管理
• 伤口治疗
• 化妆品应用
• 其他

第 7 章光生物刺激设备的全球市场：按最终用户划分

• 专科诊所
• 研究院
• 家庭医疗护理
• 其他

第 8 章全球光生物刺激设备市场：竞争格局

• 摘要
• 各公司的市场排名
• 主要发展策略

第九章公司简介

• Lumenis
• BIOPTRON AG
• PhotoMedex Inc.
• Zimmer Biomet
• IRRAS
• LiteCure LLC
• Mettler Electronics Corp.
• TheraLight LLC
• Quantum Devices Inc.
• Diomed Medical Group

第10章主要进展

• 产品发布/开发
• 併购
• 业务扩展
• 合作伙伴与联盟

第11章附录

• 相关研究

Photobiostimulation Devices Market Valuation - 2024-2031

The growing inclination toward non-invasive and drug-free therapeutic techniques is driven by increased awareness of their efficacy and safety, fueling demand for photobiostimulation devices. According to the analyst from Verified Market Research, the Photobiostimulation Devices Market is estimated to reach a valuation of USD 313.64 Million over the forecast subjugating aroundUSD 195.82 Million valued in 2023.

The market is gaining pace as healthcare professionals and consumers recognize the benefits of photobiostimulation therapy, resulting in increased usage of these devices in a variety of healthcare settings and enabling the market to grow at aCAGR of 6.07% from 2024 to 2031.

Photobiostimulation Devices Market: Definition/ Overview

Photobiostimulation devices, also known as low-level laser treatment (LLLT) or cold lasers, use certain wavelengths of light to activate cellular processes in the body. These devices produce non-thermal, low-intensity light that is absorbed by cells, resulting in a variety of biochemical responses that promote healing and tissue regeneration. In essence, photobiostimulation uses the therapeutic characteristics of light to accelerate the body's natural healing processes without causing harm.

Furthermore, these devices are utilized in a variety of medical and aesthetic disciplines. They are used in healthcare to control pain, reduce inflammation, and relieve musculoskeletal pain caused by illnesses such as arthritis, tendonitis, and sports injuries. Photobiostimulation devices are also used in wound healing to promote speedier recovery from both acute and chronic wounds, such as diabetic ulcers.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Which are the Drivers Fostering Growth of Photobiostimulation Devices?

The world's population is becoming more and more affected by chronic illnesses such as neuropathic pain, musculoskeletal disorders, and arthritis. As a result, photobiostimulation devices help manage pain, decrease inflammation, and encourage tissue healing in various situations, increasing the demand for such therapeutic options.

Non-invasive methods for pain management and rehabilitation have gained substantial traction among healthcare professionals and patients. This trend is supported by a rising amount of clinical evidence demonstrating the efficacy and safety of photobiostimulation therapy, contributing to its increasing adoption.

Furthermore, continuous advancements in laser and LED technology have resulted in the creation of more effective, portable, and user-friendly photobiostimulation devices. These technical advancements not only improve therapeutic efficacy but also make these devices more accessible for home use, hence growing the market.

Which are the Limitations Restraining Growth of Photobiostimulation Devices Market?

Despite their potential benefits, photobiostimulation devices are viewed skeptically by both the medical establishment and consumers. Convincing healthcare providers and patients to use new technology is tough, especially when there is little awareness or comprehension of how these devices work. As a result, it acts as a significant obstacle for the market.

Obtaining insurance reimbursement for photobiostimulation therapies is possible to be problematic. Many insurance companies are cautious to accept novel or developing treatments unless there is strong evidence of their cost-effectiveness and long-term benefits. This limits patient access to these medicines because some treatments may be prohibitively expensive for some patients to pay out of pocket.

Furthermore, approval from regulatory organizations such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is a substantial barrier. These devices have to satisfy high safety and efficacy requirements, and the approval process can be lengthy and expensive.

Category-Wise Acumens

How will Sales of Infrared Light Fare for The Market?

According to VMR analysis, the infrared light segment is estimated to hold the largest market share in the type segment during the forecast period. Infrared light treatment is used for a variety of purposes, including pain relief, inflammation reduction, muscle repair, and wound healing. Its versatility appeals to a wide range of users, including medical professionals, physical therapists, and patients seeking at-home therapy choices. This diverse range of applications helps to explain the reason infrared light devices are more widely used than other types of photobiostimulation devices.

Infrared light penetrates deeper into tissues than red light or other forms of light utilized in photobiostimulation. This deeper penetration is critical for treating problems that occur in deeper layers of tissue, making infrared devices particularly beneficial for a wide range of medical and therapeutic applications, including muscle discomfort, joint issues, and certain types of chronic pain. The capacity to penetrate deeper tissues increases the utility and effectiveness of infrared photobiostimulation devices, contributing to their dominant market position.

Furthermore, infrared light therapy's efficacy and safety have been validated by extensive clinical evidence, resulting in regulatory approval for a wide range of medical and therapeutic applications. This robust clinical backing reassures both healthcare providers and patients, encouraging the use of infrared light equipment. Regulatory approvals also assist the introduction of these technologies into mainstream healthcare settings, increasing their market penetration.

Which Drivers Boost Applications of Pain Management in the Market?

The pain management segment is estimated to grow at the highest CAGR in the Photobiostimulation Devices Market during the forecast period. The rising prevalence of chronic pain diseases such as arthritis, back pain, and neck pain, among others, adds significantly to the demand for pain management solutions. Photobiostimulation devices provide a non-invasive, drug-free pain relief option that appeals to a diverse variety of individuals seeking alternatives to pharmaceutical pain management.

Photobiostimulation devices are becoming increasingly popular among healthcare practitioners for pain management. This is due to a substantial body of clinical evidence demonstrating their usefulness in pain management and tissue healing. As these devices become more integrated into normal pain management protocols, their market share in this segment is increasing.

Furthermore, technological improvements have improved the effectiveness, affordability, and accessibility of photobiostimulation devices. Innovations in device design, such as portability and ease of use, have allowed patients to utilize these devices at home, increasing their popularity for pain management.

Country/Region-wise Acumens

Which Drivers Support North America's Dominant Position in the Market?

According to VMR analyst, North America is estimated to dominate the Photobiostimulation Devices Market during the forecast period. North America is demonstrating an increasing preference for non-invasive treatment choices. Photobiostimulation devices, which offer a non-invasive technique for controlling chronic pain, wound healing, and cosmetic applications, connect well with this trend and are becoming increasingly popular in the region.

North America is home to several competitors in the market, contributing to the region's dominant position in the photobiostimulation device market. The region's inclination towards adopting technologically advanced, minimally invasive therapies promoting the development and use of photobiostimulation devices. The region's strong healthcare infrastructure and high healthcare expenditure support market growth.

Furthermore, the regulatory framework in North America, particularly in the United States, promotes innovation and speedy clearance of medical devices, including photobiostimulation devices. This environment stimulates companies to create and commercialise innovative and effective therapies, boosting market growth.

What Variables Influence the Demand for these Devices in Asia Pacific Region?

Asia Pacific is estimated to grow at the highest CAGR within the market during the forecast period. Asia Pacific has a large and expanding elderly population, making it more vulnerable to chronic illnesses that can be addressed using photobiostimulation devices, such as pain relief, wound treatment, and cosmetic applications. As these illnesses become more common, there is a greater need for photobiostimulation therapy.

Countries in Asia Pacific, particularly China and India, are experiencing significant economic expansion, resulting in higher healthcare spending. Such economic growth has increased access to healthcare services and modern medical technologies, such as photobiostimulation devices.

Furthermore, this region is experiencing an increase in the use of non-invasive treatments. Photobiostimulation devices are a non-invasive alternative to standard medical treatments for a range of illnesses, matching patient preferences and driving market expansion in the region.

Competitive Landscape

The Photobiostimulation Devices Market is characterized by dynamic interactions between numerous companies competing for market share. Market companies are constantly striving to differentiate themselves by developing innovative photobiostimulation devices with improved efficacy, safety features, and usability.

Some of the prominent players operating in the Photobiostimulation Devices Market include:

Lumenis, BIOPTRON AG, PhotoMedex Inc., Zimmer Biomet, IRRAS, LiteCure LLC, Mettler Electronics Corp., TheraLight LLC, Quantum Devices Inc., Diomed Medical Group, Aktiia, BIOLUX, INTERNATIONAL CORP., CellGen Therapeutics, Cytalux Corporation, LED Medical Diagnostics Inc., LG Innotek, Koninklijke Philips N.V., MOSER BAER AG, PhotoSonix Medical Inc., and Verilux Inc.

Latest Developments

In February 2024, BIOPTRON AG presented positive clinical data on the use of photobiostimulation treatment devices for wound healing at the Dubai World Dermatology Congress. The study discovered that the therapy dramatically decreased healing time while improving patient outcomes.

In February 2024, MOSER BAER announced an increase in its LED manufacturing capacity to accommodate the growing demand for photobiostimulation devices. This investment will allow the company to help its customers grow in this area.

In January 2024, PhotoMedex established a strategic agreement with Zimmer Biomet to develop and commercialise photobiostimulation devices for orthopaedic purposes. This alliance aims to harness both organisations' expertise to bring innovative ideas to market.

In October 2023, Philips announced a collaboration with the University of Amsterdam to investigate the use of photobiostimulation to treat brain problems. This collaboration seeks to investigate the potential of this technology for neurological applications.

In October 2023, Lumenis announced the Aculight(TM) Cynosure Laser System, a photobiostimulation therapy device to treat chronic pain and inflammation. The company says that the system has deeper tissue penetration and faster treatment times than previous models.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porter Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY TYPE

• 5.1 Overview
• 5.2 Infrared Light
• 5.3 Red Light
• 5.4 Others

6 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Pain Management
• 6.3 Wound Care
• 6.4 Cosmetic Applications
• 6.5 Others

7 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY END USER

• 7.1 Specialty Clinics
• 7.2 Research Institutes
• 7.3 Home Care
• 7.4 Others

8 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Lumenis
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 BIOPTRON AG
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 PhotoMedex Inc.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Zimmer Biomet
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 IRRAS
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 LiteCure LLC
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key DevelopmentS
• 9.7 Mettler Electronics Corp.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 TheraLight LLC
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Quantum Devices Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Diomed Medical Group
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research